The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

BACKGROUND: There are substantial differences in accessibility to biological disease modifying antirheumatic drugs (bDMARDs) across countries. The objective of this study was to analyse the impact of patient demographics, disease characteristics and gross domestic product (GDP) on abatacept (ABA) re...

Descripción completa

Detalles Bibliográficos
Autores principales: Finckh, A, Neto, D, Iannone, F, Loza, E, Lie, E, van Riel, P, Hetland, M L, Pavelka, K, Gottenberg, J E, Canhão, H, Mariette, X, Turesson, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613166/
https://www.ncbi.nlm.nih.gov/pubmed/26509062
http://dx.doi.org/10.1136/rmdopen-2014-000040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613166/
https://www.ncbi.nlm.nih.gov/pubmed/26509062
http://dx.doi.org/10.1136/rmdopen-2014-000040

Ejemplares similares